To view the PDF file, sign up for a MySharenet subscription.

DIS-CHEM PHARMACIES LIMITED - Directors dealing in securities

Release Date: 15/02/2018 17:44
Code(s): DCP     PDF:  
Wrap Text
Directors dealing in securities

(Incorporated in the Republic of South Africa)
(Registration number 2005/009766/06)
JSE share code: DCP
ISIN: ZAE000227831


In compliance with paragraphs 3.63 to 3.74 of the Listings Requirements of the JSE Limited,
shareholders are advised of the following transaction by an associate of a director in the Company’s

 Name of directors:                     Ivan Saltzman, Lynette Saltzman and Saul Saltzman
 Name of associate:                     Ivlyn Proprietary Limited (wholly-owned by the Saltzman
                                        Family Trust, in which Ivan, Lynette and Saul Saltzman have
                                        a beneficial interest)
 Class of securities:                   Ordinary shares
 Nature of transaction:                 Disposal of shares to Ivlyn No 4 Proprietary Limited (a wholly
                                        owned subsidiary of Ivlyn Proprietary Limited) for purposes of
                                        the reorganisation of the Saltzman family’s interest in
 Date of transaction:                   13 February 2018
 Number of securities:                  453,041,396
 Price per security:                    R36,38
 Value of transaction:                  R16 481 645 986,48
 Nature and extent of interest:         Indirect beneficial
 Clearance to deal:                     Yes

15 February 2018

The Standard Bank of South Africa Limited

Date: 15/02/2018 05:44:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Email this JSE Sens Item to a Friend.

Share This Story